Patients with COVID-19 would possibly return to hospitals after recovery as new dimensions of post-COVID subacute morbidities appear, as well as respiratory symptoms, immune reactions in youth and pulmonary fibrosis, the government said.
This happened after Union Interior Minister Amit Shah entered AIIMS in New Delhi on 18 August for post-COVID care after complaining of fatigue and pain and discomfort.at Medanta Hospital, he said on August 14 that he had tested negative for the disease.
Dr. VK Paul, a member (health), NITI Aayog said this was declining to some extent, but not to a dangerously alarming level, according to a Mint report.But all be especially careful because the new coronavirus can also cause damage after the recovery phase, Paul said.
“We will use the remedies we have with us as needed to deal with these cases,” Dr. Paul said.
Paul added that the clinical and medical network tracks him down.
Follow our live blog for updates on the new coronavirus pandemic
Speaking about the COVID-19 crisis in India, Paul said the slow rise in recovery rates and the minimisation of mortality rates are “reassuring” and are “positive signs” indicating that the COVID-19 pandemic is under control.
“In addition, the number of COVID-1nine tests consistent with the day is greater than nine lakh consistent with the day, which is remarkable.Testing is the key to containing the disease and reducing mortality and outcomes,” he said.
Declaring that he has realized that some others are relaxing about maintaining the norms of social estating, hand hygiene and dressing in masks, Paul warned that this can result in the loss of achievements that have been achieved so far.
On the decline of new instances over the more than five days, Paul said that while the weekly COVID-19 stage update is reassuring, the challenge is not yet over.
“There is a giant vulnerable population in the country, so the virus still has a chance of harming us,” he said.
On the vaccine front, Paul, who chairs the national organization specializing in the management of vaccines opposed to COVID-19, referred to the Prime Minister’s speech on Independence Day that 3 vaccines are being developed in India and are in the stages of human trials.
“One of them will enter a phase 3 trial or tomorrow.The other two are in phase 1 and 2.We have analyzed the candidate vaccines and smart progress is being made,” he said.-declares.
A review of the vaccine’s chain of origin is ready and how it would be obtained, Paul added.
(With PTI inputs)
Coronavirus Essential Unlock 4.0 in India; The Oxford vaccine arrives in phase 3 trials in the US.Usa, Trump says